EX-99.1 2 d577210dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

PRESS RELEASE    LOGO

 

 

Amdocs Limited Reports Record Quarterly Revenue of $841M, Up 4.0% YoY

Expects FY2013 Non-GAAP EPS Growth Towards the Higher-End of the Previous Expectation of 5-8%

Key highlights:

 

   

Third fiscal quarter revenue of $841 million, within the $825-$855 million guidance range. Foreign currency movements negatively affected revenue by approximately $4 million relative to the second quarter of fiscal 2013

 

   

Third fiscal quarter non-GAAP operating income of $142 million; non-GAAP operating margin of 16.8%; GAAP operating income of $123 million

 

   

Third fiscal quarter diluted non-GAAP EPS of $0.83, compared to the $0.70-$0.76 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects. A lower non-GAAP effective tax rate positively impacted diluted non-GAAP EPS by approximately $0.10

 

   

Diluted GAAP EPS of $0.73 for the third fiscal quarter, compared to the $0.60-$0.68 guidance range. A lower GAAP effective tax rate positively impacted diluted GAAP EPS by approximately $0.10

 

   

Free cash flow of $151 million for the third fiscal quarter

 

   

Twelve-month backlog of $2.83 billion at the end of the third fiscal quarter, up $20 million from the end of the second quarter of fiscal 2013

 

   

Repurchased $58 million of ordinary shares during the third fiscal quarter

 

   

The board of directors approved a $0.13 per share quarterly cash dividend to be paid on October 18, 2013

 

   

Fourth quarter fiscal 2013 guidance: Expected revenue of approximately $830-$860 million and diluted non-GAAP EPS of $0.60-$0.66, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Diluted non-GAAP EPS guidance includes an expected negative impact of approximately


 

$0.10 due to a higher non-GAAP effective tax rate in the fourth fiscal quarter. The non-GAAP effective tax rate for the full fiscal year 2013 is still anticipated to be within the previously expected range of 13%-15%. Diluted GAAP EPS is expected to be approximately $0.50-$0.58. Diluted GAAP EPS guidance includes an expected negative impact of approximately $0.10 due to a higher GAAP effective tax rate in the fourth fiscal quarter.

ST. LOUIS – July 31, 2013 – Amdocs Limited (NYSE: DOX) today reported that for its fiscal quarter ended June 30, 2013, revenue was $841.3 million, up 1.0% sequentially from the second fiscal quarter of 2013 and up 4.0% as compared to last year’s third fiscal quarter. Net income on a non-GAAP basis was $134.4 million, or $0.83 per diluted share, compared to non-GAAP net income of $118.4 million, or $0.70 per diluted share, in the third quarter of fiscal 2012. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $14.9 million, net of related tax effects, in the third quarter of fiscal 2013 and excludes such amortization and other acquisition related costs and equity-based compensation expenses of $19.6 million, net of related tax effects, in the third quarter of fiscal 2012. The Company’s GAAP net income for the third quarter of fiscal 2013 was $119.6 million, or $0.73 per diluted share, compared to GAAP net income of $98.8 million, or $0.59 per diluted share, in the prior fiscal year’s third quarter.

“We are pleased with our solid performance in the third fiscal quarter. Despite currency headwinds, we delivered revenue growth of 4% year-over-year, driven by continued strength in North America. AT&T was an important contributor to our performance, and we are also seeing growth at other key customers in North America. In the emerging markets, we remain focused on bringing many highly complex transformation projects into production, and we continue to see a substantial pipeline of opportunity with new and existing customers. Finally, in Europe, while overall economic conditions in the region remain challenging, we delivered another quarter of relatively consistent revenue on a sequential basis” said Eli Gelman, chief executive officer of Amdocs Management Limited.

Gelman continued, “We continued to sign strategic customer wins during the third fiscal quarter. In North America, Amdocs was selected by Aio Wireless, a new, no-annual-contract wireless service, to provide managed services across Amdocs’ business support systems


(BSS), web portal and mobile applications, as well as to manage third party applications. In Europe, we signed a five-year managed services agreement with a major European wireless group to manage its customer care and billing systems in a newly established shared services and development center. In replacing a number of vendors with Amdocs, we believe this agreement is evidence of the value Amdocs can bring with managed services in Europe as operators seek to simplify and improve the quality of their operations. The contracts with Aio and the European operator demonstrate Amdocs’ ability to deliver value, and, as such, grow our business in existing customers through the breadth of our product family and our expanded services capabilities that extend beyond Amdocs’ own systems.”

Gelman concluded, “As we embark on the fourth fiscal quarter, we will continue to monitor macroeconomic and industry conditions closely. These include the near term uncertainty arising from the effects of consolidation amongst North American carriers, challenging conditions in Europe, and some slowdown in subscriber and economic growth in segments of the emerging markets, all of which can affect the pace and scope of business demand. We remain keenly focused on our growth initiatives, our operational execution and capital efficiency. As a result, we now expect to deliver non-GAAP EPS growth towards the higher end of our prior expectation of 5-8%.”

Financial Discussion of Third Fiscal Quarter Results

Free cash flow was $151 million for the quarter, comprised of cash flow from operations of $173 million less $22 million in net capital expenditures and other.

Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.83 billion at the end of the third quarter of fiscal 2013.

Financial Outlook

Amdocs expects that revenue for the fourth quarter of fiscal 2013 will be approximately $830-$860 million. Diluted earnings per share on a non-GAAP basis for the fourth fiscal quarter are expected to be $0.60-$0.66, excluding amortization of purchased intangible assets and other acquisition-related costs and approximately $0.04-$0.05 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the fourth fiscal quarter will be $0.50-$0.58.


Quarterly Cash Dividend Program

On July 31, 2013, the Board approved the Company’s next quarterly cash dividend payment and set September 30, 2013 as the record date for determining the shareholders entitled to receive the dividend, which is payable on October 18, 2013.

Conference Call Details

Amdocs will host a conference call on July 31, 2013 at 5:00 p.m. Eastern Time to discuss the Company’s third fiscal quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.

Non-GAAP Financial Measures

This release includes non-GAAP diluted earnings per share and other non-GAAP financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP earnings per share growth. These non-GAAP measures exclude the following items:

 

   

amortization of purchased intangible assets and other acquisition related costs;

 

   

gain on sale of investment;

 

   

equity-based compensation expense; and

 

   

tax effects related to the above.

These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.


Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP interest and other expense, net, non-GAAP income taxes, non-GAAP effective tax rate, non-GAAP net income and non-GAAP earnings per share growth when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.

For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, gain on sale of investment, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these items in reviewing its results and those of its competitors, because the amounts of the items between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the items.

Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, interest and other expense, net, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments. Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.


About Amdocs

For 30 years, Amdocs has ensured service providers’ success and embraced their biggest challenges. To win in the connected world, service providers rely on Amdocs to simplify the customer experience, harness the data explosion, stay ahead with new services and improve operational efficiency. The global company uniquely combines a market-leading BSS, OSS and network control product portfolio with value-driven professional services and managed services operations. With revenue of $3.2 billion in fiscal 2012, Amdocs and its approximately 20,000 employees serve customers in more than 60 countries.

Amdocs: Embrace Challenge, Experience Success.

For more information, visit Amdocs at www.amdocs.com.

This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs’ growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs’ ability to grow in the business markets that it serves, Amdocs’ ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2012 filed on December 11, 2012, our Form 6-K furnished for the first quarter of fiscal 2013 on February 12, 2013 and our Form 6-K furnished for the second quarter of fiscal 2013 on May 16, 2013.

Contact:

Elizabeth W. Grausam McDermon

Vice President, Corporate Strategy and Investor Relations

Amdocs

314-212-8328

E-mail: dox_info@amdocs.com


AMDOCS LIMITED

Consolidated Statements of Income

(in thousands, except per share data)

 

     Three months ended
June 30,
     Nine months ended
June 30,
 
     2013      2012      2013      2012  

Revenue:

           

License

   $ 18,616       $ 34,443       $ 59,433       $ 96,477   

Service

     822,716         774,394         2,441,196         2,328,298   
  

 

 

    

 

 

    

 

 

    

 

 

 
     841,332         808,837         2,500,629         2,424,775   

Operating expenses:

           

Cost of license

     561         1,056         1,839         2,982   

Cost of service

     546,108         519,217         1,619,215         1,552,947   

Research and development

     59,583         58,858         179,002         180,515   

Selling, general and administrative

     103,396         106,678         313,539         319,857   

Amortization of purchased intangible assets and other

     8,520         12,977         28,358         39,503   
  

 

 

    

 

 

    

 

 

    

 

 

 
     718,168         698,786         2,141,953         2,095,804   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating income

     123,164         110,051         358,676         328,971   

Interest and other expense, net

     2,726         2,737         4,591         1,064   
  

 

 

    

 

 

    

 

 

    

 

 

 

Income before income taxes

     120,438         107,314         354,085         327,907   

Income taxes

     880         8,565         30,600         34,557   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 119,558       $ 98,749       $ 323,485       $ 293,350   
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic earnings per share

   $ 0.74       $ 0.59       $ 2.00       $ 1.73   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted earnings per share

   $ 0.73       $ 0.59       $ 1.98       $ 1.72   
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic weighted average number of shares outstanding

     160,914         167,194         161,350         169,890   
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted weighted average number of shares outstanding

     162,667         168,290         163,048         171,033   
  

 

 

    

 

 

    

 

 

    

 

 

 

Cash dividends declared per share

   $ 0.13       $ —         $ 0.39       $ —     
  

 

 

    

 

 

    

 

 

    

 

 

 


AMDOCS LIMITED

Selected Financial Metrics

(in thousands, except per share data)

 

     Three months ended
June 30,
     Nine months ended
June 30,
 
     2013      2012      2013      2012  

Revenue

   $ 841,332       $ 808,837       $ 2,500,629       $ 2,424,775   

Non-GAAP operating income

     141,551         134,338         418,935         401,457   

Non-GAAP net income

     134,430         118,357         373,154         344,314   

Non-GAAP diluted earnings per share

   $ 0.83       $ 0.70       $ 2.29       $ 2.01   

Diluted weighted average number of shares outstanding

     162,667         168,290         163,048         171,033   


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

 

     Three months ended
June 30, 2013
 
            Reconciliation items        
     GAAP      Amortization of
purchased  intangible
assets and other
    Equity based
compensation
expense
    Tax effect     Non-GAAP  

Operating expenses:

           

Cost of license

   $ 561       $ —        $ —        $ —        $ 561   

Cost of service

     546,108         —          (4,937     —          541,171   

Research and development

     59,583         —          (1,060     —          58,523   

Selling, general and administrative

     103,396         —          (3,870     —          99,526   

Amortization of purchased intangible assets and other

     8,520         (8,520     —          —          —     
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     718,168         (8,520     (9,867     —          699,781   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     123,164         8,520        9,867        —          141,551   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     880         —          —          3,515        4,395   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 119,558       $ 8,520      $ 9,867      $ (3,515   $ 134,430   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

     Three months ended
June 30, 2012
 
            Reconciliation items        
     GAAP      Amortization of
purchased intangible
assets and other
    Equity based
compensation
expense
    Tax effect     Non-GAAP  

Operating expenses:

           

Cost of license

   $ 1,056       $ —        $ —        $ —        $ 1,056   

Cost of service

     519,217         —          (6,010     —          513,207   

Research and development

     58,858         —          (1,068     —          57,790   

Selling, general and administrative

     106,678         —          (4,232     —          102,446   

Amortization of purchased intangible assets and other

     12,977         (12,977     —          —          —     
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     698,786         (12,977     (11,310     —          674,499   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     110,051         12,977        11,310        —          134,338   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     8,565         —          —          4,679        13,244   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 98,749       $ 12,977      $ 11,310      $ (4,679   $ 118,357   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP

(in thousands)

 

     Nine months ended
June 30, 2013
 
            Reconciliation items        
     GAAP      Amortization of
purchased intangible
assets and other
    Equity based
compensation
expense
    Tax effect     Non-GAAP  

Operating expenses:

           

Cost of license

   $ 1,839       $ —        $ —        $ —        $ 1,839   

Cost of service

     1,619,215         —          (14,440     —          1,604,775   

Research and development

     179,002         —          (3,060     —          175,942   

Selling, general and administrative

     313,539         —          (14,401     —          299,138   

Amortization of purchased intangible assets and other

     28,358         (28,358     —          —          —     
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     2,141,953         (28,358     (31,901     —          2,081,694   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     358,676         28,358        31,901        —          418,935   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     30,600         —          —          10,590        41,190   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 323,485       $ 28,358      $ 31,901      $ (10,590   $ 373,154   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

     Nine months ended
June 30, 2012
 
            Reconciliation items        
     GAAP      Amortization of
purchased intangible
assets and other
    Equity based
compensation
expense
    Gain on sale
of
investment
    Tax effect     Non-GAAP  

Operating expenses:

             

Cost of license

   $ 2,982       $ —        $ —        $ —        $ —        $ 2,982   

Cost of service

     1,552,947         —          (17,376     —          —          1,535,571   

Research and development

     180,515         —          (3,281     —          —          177,234   

Selling, general and administrative

     319,857         —          (12,326     —          —          307,531   

Amortization of purchased intangible assets and other

     39,503         (39,503     —          —          —          —     
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     2,095,804         (39,503     (32,983     —          —          2,023,318   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     328,971         39,503        32,983        —          —          401,457   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Interest and other expense, net

     1,064         —          —          6,270        —          7,334   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

     34,557         —          —          —          15,252        49,809   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 293,350       $ 39,503      $ 32,983      $ (6,270   $ (15,252   $ 344,314   
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 


AMDOCS LIMITED

Condensed Consolidated Balance Sheets

(in thousands)

 

     As of  
     June 30,
2013
     September 30,
2012
 

ASSETS

     

Current assets

     

Cash, cash equivalents and short-term interest-bearing investments

   $ 1,090,699       $ 1,118,177   

Accounts receivable, net, including unbilled of $124,197 and $130,697, respectively

     667,748         687,223   

Deferred income taxes and taxes receivable

     124,395         109,282   

Prepaid expenses and other current assets

     162,737         126,388   
  

 

 

    

 

 

 

Total current assets

     2,045,579         2,041,070   

Equipment and leasehold improvements, net

     261,933         277,907   

Goodwill and other intangible assets, net

     1,854,435         1,883,064   

Other noncurrent assets

     398,872         443,182   
  

 

 

    

 

 

 

Total assets

   $ 4,560,819       $ 4,645,223   
  

 

 

    

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

     

Current Liabilities

     

Accounts payable, accruals and other

   $ 602,699       $ 690,823   

Short-term financing arrangements

     —           200,000   

Deferred revenue

     133,060         145,184   

Deferred income taxes and taxes payable

     38,058         29,551   
  

 

 

    

 

 

 

Total current liabilities

     773,817         1,065,558   

Other noncurrent liabilities

     547,205         546,463   

Shareholders’ equity

     3,239,797         3,033,202   
  

 

 

    

 

 

 

Total liabilities and shareholders’ equity

   $ 4,560,819       $ 4,645,223   
  

 

 

    

 

 

 


AMDOCS LIMITED

Consolidated Statements of Cash Flows

(in thousands)

 

     Nine months ended June 30,  
     2013     2012  

Cash Flow from Operating Activities:

    

Net income

   $ 323,485      $ 293,350   

Reconciliation of net income to net cash provided by operating activities:

    

Depreciation and amortization

     107,400        119,261   

Equity-based compensation expense

     31,901        32,983   

Deferred income taxes

     1,829        (13,587

Excess tax benefit from equity-based compensation

     (275     (140

Gain on sale of investment

     —          (9,172

Loss from short-term interest-bearing investments

     1,873        2,403   

Net changes in operating assets and liabilities:

    

Accounts receivable

     31,559        (101,302

Prepaid expenses and other current assets

     (12,010     (11,222

Other noncurrent assets

     23,056        21,559   

Accounts payable, accrued expenses and accrued personnel

     (59,279     41,501   

Deferred revenue

     (18,360     (19,415

Income taxes payable

     (14,391     11,053   

Other noncurrent liabilities

     22,054        (5,259
  

 

 

   

 

 

 

Net cash provided by operating activities

     438,842        362,013   
  

 

 

   

 

 

 

Cash Flow from Investing Activities:

    

Payments for purchase of equipment and leasehold improvements, net

     (80,151     (79,223

Proceeds from sale of short-term interest-bearing investments

     258,121        288,334   

Purchase of short-term interest-bearing investments

     (324,982     (257,958

Cash received from sale of investment

     —          11,172   

Other

     (4,161     (6,237
  

 

 

   

 

 

 

Net cash used in investing activities

     (151,173     (43,912
  

 

 

   

 

 

 

Cash Flow from Financing Activities:

    

Payments under financing arrangements

     (200,000     (250,000

Repurchase of shares

     (270,251     (378,404

Proceeds from employee stock options exercised

     154,105        63,085   

Payments of dividends

     (63,079     —     

Payments under capital lease and other

     (825     (383
  

 

 

   

 

 

 

Net cash used in financing activities

     (380,050     (565,702
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (92,381     (247,601

Cash and cash equivalents at beginning of period

     879,158        831,371   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 786,777      $ 583,770   
  

 

 

   

 

 

 


AMDOCS LIMITED

Supplementary Information

(in millions)

 

     Three months ended  
     June 30,
2013
     March 31,
2013
     December 31,
2012
     September 30,
2012
     June 30,
2012
 

North America

   $ 619.2       $ 601.3       $ 593.6       $ 570.4       $ 558.7   

Europe

     98.0         99.3         99.2         113.1         106.5   

Rest of World

     124.1         132.3         133.6         138.6         143.6   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 841.3       $ 832.9       $ 826.4       $ 822.1       $ 808.8   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended  
     June 30,
2013
     March 31,
2013
     December 31,
2012
     September 30,
2012
     June 30,
2012
 

Emerging Markets Revenue

   $ 101.3       $ 98.1       $ 98.2       $ 99.9       $ 101.7   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended  
     June 30,
2013
     March 31,
2013
     December 31,
2012
     September 30,
2012
     June 30,
2012
 

Managed Services Revenue

   $ 417.1       $ 439.8       $ 429.8       $ 423.7       $ 426.8   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended  
     June 30,
2013
     March 31,
2013
     December 31,
2012
     September 30,
2012
     June 30,
2012
 

Customer Experience Systems

   $ 803.2       $ 789.3       $ 783.8       $ 783.1       $ 766.2   

Directory

     38.1         43.6         42.6         39.0         42.6   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 841.3       $ 832.9       $ 826.4       $ 822.1       $ 808.8   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
     As of  
     June 30,
2013
     March 31,
2013
     December 31,
2012
     September 30,
2012
     June 30,
2012
 

12-Month Backlog

   $ 2,830       $ 2,810       $ 2,800       $ 2,790       $ 2,760   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

# # #